← All organizations
Highest phase reached
Phase 4
First clinical trial
Apr 19, 2020Last known activity
Sep 1, 2023
Timeline
No events for the selected filters.
Drugs by trial phase (12 distinct, 7 trials)
Phase 4 (2 own, 0 via acquisition)
Phase 3 (2 own, 0 via acquisition)
Indications
Studied for
Recent trials (12)
- NCT06187922Sponsor investigatorPhase 4Sep 1, 2023
- NCT06187922Lead sponsorPhase 4Sep 1, 2023
- NCT04827966Reponsible party - principal investigatorN/ADec 1, 2021
- NCT04827966Lead sponsorN/ADec 1, 2021
- NCT04854876CollaboratorN/AAug 15, 2021
- NCT04854876Overall official - principal investigatorN/AAug 15, 2021
- NCT04542850CollaboratorN/ANov 15, 2020
- NCT04542850Overall official - principal investigatorN/ANov 15, 2020
- NCT04390815Reponsible party - principal investigatorPhase 4Aug 31, 2020
- NCT04390815Lead sponsorPhase 4Aug 31, 2020
- NCT04387760CollaboratorPhase 2/Phase 3May 14, 2020
- NCT04356534CollaboratorN/AApr 19, 2020
Details
- Last known activity
- Sep 1, 2023